We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 28, 2023

Safety of Biologics in Patients With Severe Asthma and SARS-CoV-2 Infection

Pediatric Pulmonology


Additional Info

Disclosure statements are available on the authors' profiles:

Pediatric Pulmonology
Safety of biologics in severe asthmatic patients with SARS-CoV-2 infection: A prospective study
Pediatr. Pulmonol. 2023 Jan 02;[EPub Ahead of Print], S Manti, A Giallongo, G Pecora, GF Parisi, M Papale, E Mulè, D Aloisio, N Rotolo, S Leonardi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading